Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vallon Pharmaceuticals (VLON)

Vallon Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VLON
DateTimeSourceHeadlineSymbolCompany
11/09/202420:36Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VLONVallon Pharmaceuticals Inc
06/09/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
28/08/202421:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
28/08/202421:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
28/08/202421:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
23/08/202420:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VLONVallon Pharmaceuticals Inc
23/08/202420:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VLONVallon Pharmaceuticals Inc
23/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
16/08/202412:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VLONVallon Pharmaceuticals Inc
14/08/202412:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
02/08/202421:21Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VLONVallon Pharmaceuticals Inc
02/08/202421:19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VLONVallon Pharmaceuticals Inc
26/07/202420:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
26/07/202420:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VLONVallon Pharmaceuticals Inc
23/07/202420:09Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VLONVallon Pharmaceuticals Inc
19/07/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
19/07/202420:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VLONVallon Pharmaceuticals Inc
08/07/202413:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
27/06/202420:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:VLONVallon Pharmaceuticals Inc
27/06/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
27/06/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VLONVallon Pharmaceuticals Inc
26/06/202420:03Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VLONVallon Pharmaceuticals Inc
18/06/202420:54Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
18/06/202420:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
18/06/202420:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
14/06/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
07/06/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
31/05/202419:34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
31/05/202419:32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VLONVallon Pharmaceuticals Inc
22/05/202420:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VLONVallon Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VLON